搜尋結果
Sarepta's Stock Soars on Best-Case FDA Decision for its Muscular Dystrophy Treatment
The Wall Street Journal· 12 小時前For biotech companies, regulatory approval is usually one of many steps needed to convince Wall ...
Eli Lilly expects FDA decision on weight loss drug Zepbound for sleep apnea as early as end of ...
CNBC· 7 小時前If cleared by the Food and Drug Administration, the company plans to launch Zepbound for< ...
Laos’ runaway inflation forces some to flee, others to get creative
South China Morning Post· 5 日前Highly dependent on imports, the Southeast Asian nation has seen prices for basic necessities, ...
India cenbank's rate panel views diverge further amid fears of growth sacrifice
Reuters· 14 小時前The Reserve Bank of India's rate panel has diverged further in its views on the need for< ...
Focus: Food companies with Ozempic-friendly snacks and meals wade carefully into weight-loss ...
Reuters· 2 日前, opens new tab new food brand for people taking weight-loss drugs like Wegovy will ... ...
Tesla makes Musk best-paid CEO of all time and Fisker bites the dust
TechCrunch· 8 小時前Shareholders erupted in applause at Tesla’s Texas gigafactory when the vote results were ...
Most Japan firms see no need to follow the U.S. with tariffs on China, Reuters poll finds
Reuters· 2 日前Most Japanese companies see no need for their government to follow the U.S. in raising ... ...
Two Is Better Than One in the Alzheimer’s Market
The Wall Street Journal· 5 日前The approval of Eli Lilly’s Alzheimer’s drug donanemab could help build momentum for Biogen’s ...
Enjoy Euro 2024 on the cheap? Fans work out how
Reuters· 13 小時前Cost-conscious fans for whom budgets are tight but Euro 2024 is unmissable are parking for< ...
Biden administration bypasses Republican hold on funding for Haiti, - English News - ...
metroradio.com.hk· 1 日前U.S. President Joe Biden's administration has decided to bypass a months-long Republican hold on millions of dollars in ...